newcleo clears SPAC vote, set for Nasdaq debut as NWCL

newcleo plc, a UK-registered developer of lead-cooled advanced modular reactors (AMRs) and nuclear fuel recycling facilities, is on course for a Nasdaq listing after shareholders of NewHold Investment Corp. III voted overwhelmingly in favour of the companies' merger on 17 September 2026. Roughly 93.4% of votes cast supported the business combination, representing approximately 72.4% of NewHold's outstanding shares. The deal is expected to close around 21 September, with newcleo shares and warrants trading under the tickers NWCL and NWCLW from approximately 22 September.

The transaction is structured as a special purpose acquisition company (SPAC) merger, a route that lets a private company access public capital markets by combining with a listed blank-cheque vehicle. NewHold raised capital from public investors with the explicit purpose of identifying an acquisition target; its combination with newcleo gives the nuclear developer a public currency and, subject to redemption levels, additional cash for its technology programme. The release did not disclose the gross proceeds expected from the transaction or the level of shareholder redemptions, both of which will materially affect the cash the combined company retains.

The company and its technology

newcleo was founded by physicist and entrepreneur Stefano Buono, who previously built Advanced Accelerator Applications, a Nasdaq-listed nuclear medicine business sold to Novartis for approximately $3.9 billion. The company has raised around $800 million in private funding and employs more than 900 people across Europe and the United States. Its technology centres on lead-cooled fast reactors, a generation IV reactor concept that uses liquid lead as a coolant rather than water. The company also develops mixed-oxide (MOX) fuel, a process that reprocesses spent nuclear fuel into new fuel assemblies, positioning it as a vertically integrated nuclear energy and fuel supply business.

newcleo says it has built a network of more than 100 industry partnerships and has been acquiring companies along the nuclear supply chain. The company has not yet deployed a commercial reactor, and its technology remains at the demonstration and licensing stage across multiple jurisdictions, including the United Kingdom, France, Italy and the United States.

Market context and policy backdrop

Advanced modular reactors and small modular reactors (SMRs) have attracted growing institutional and government attention as potential sources of firm, low-carbon electricity to complement intermittent wind and solar. Lead-cooled fast reactor designs, while less commercially advanced than pressurised-water SMR concepts, are seen by proponents as offering superior fuel efficiency and the ability to reduce long-lived nuclear waste volumes. Several developers, including NuScale, Kairos Power and TerraPower in North America, are at varying stages of regulatory review; newcleo's Nasdaq listing signals an ambition to compete for international capital alongside these peers.

Policy tailwinds are meaningful. The US Department of Energy has backed advanced reactor demonstration programmes, and the UK government has included AMRs in its nuclear roadmap. In the European Union, nuclear has been classified as a transitional activity under the taxonomy regulation, potentially opening access to green-labelled finance. The durability of that support, and the pace of regulatory approvals in each jurisdiction, remain the critical variables for any advanced nuclear developer.

What to watch

Investors will focus on the cash position retained after redemptions, the timeline and cost of newcleo's first demonstration reactor, progress on regulatory licensing in the UK and France, and any update to MOX fuel facility milestones. The company is pre-revenue and will require substantial additional capital beyond the SPAC proceeds to reach commercial operation.